Paul Burton
Chief Tech/Sci/R&D Officer bij AMGEN INC.
Vermogen: 101 658 $ op 31-03-2024
Profiel
Dr. Paul Burton is Chief Global Medical Affairs Officer bij Janssen Pharmaceuticals, Inc. Dr. Burton was voordien werkzaam als Vice President bij Janssen Research & Development LLC. Hij behaalde zijn doctoraatsdiploma aan de Universiteit van Londen en een doctoraatsdiploma aan het Imperial College London.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MODERNA, INC.
0.00% | 07-11-2022 | 954 ( 0.00% ) | 101 658 $ | 31-03-2024 |
Actieve functies van Paul Burton
| Bedrijven | Functie | Begin |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01-06-2023 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Chief Tech/Sci/R&D Officer | 01-03-2020 |
| Royal College of Surgeons | Corporate Officer/Principal | - |
Eerdere bekende functies van Paul Burton
| Bedrijven | Functie | Einde |
|---|---|---|
| MODERNA, INC. | Chief Tech/Sci/R&D Officer | 01-01-2023 |
| JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | - |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | - |
Opleiding van Paul Burton
| Imperial College London | Doctorate Degree |
| University of London | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| MODERNA, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
